Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2019 April;60(2) > The Journal of Cardiovascular Surgery 2019 April;60(2):205-11

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW  RECENT ADVANCES IN ATHERECTOMY IN PERIPHERAL ARTERY DISEASE 

The Journal of Cardiovascular Surgery 2019 April;60(2):205-11

DOI: 10.23736/S0021-9509.19.10844-0

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions

Michael LICHTENBERG 1 , Grigorios KOROSOGLOU 2

1 Department of Interventional Angiology, Klinikum Arnsberg, Arnsberg, Germany; 2 Department of Cardiology and Angiology, GRN Hospital Weinheim, Weinheim, Germany



Within the last years, many new endovascular treatment modalities have been invented for treatment of peripheral arterial disease. To leave nothing behind and to keep options for future treatment are key issues of these new revascularization procedures. Drug coated balloon technology (DCB) is one key element in this strategy but there are still limitations for this revascularization technology. Especially calcium rich lesions and long lesions are still challenging in terms of treatment success and long-term patency. Treatment of both calcified and long lesions continues to be a clinical challenge for every interventionalists. Therefore, a treatment combination of debulking procedure using atherectomy plus antirestenotic therapy using DCB seems to be promising to treat complex lesions.


KEY WORDS: Peripheral arterial disease - Atherectomy - Drug-eluting stents

inizio pagina